
These are the 4 biggest things we're watching in the stock market this week newsthirst.
Fed Chair Jerome Powell’s press conference and Nvidia CEO Jensen Huang’s GTC keynote are influential events.
Fed Chair Jerome Powell’s press conference and Nvidia CEO Jensen Huang’s GTC keynote are influential events.
If you receive an unsolicited text claiming to be from the Internal Revenue Service, it’s almost certainly a scam. This is especially relevant during tax season. The Better Business Bureau warns about phishing attempts in which scammers use the promise of automatic payments for $1,400 stimulus checks as a lure to steal sensitive data. While…
Goldman Sachs Asset Management is trying to serve more investors looking for downside protection from market turmoil. Bryon Lake helped the firm launch its newest buffer exchange-traded fund this month: the Goldman Sachs U.S. Large Cap Buffer 3 ETF. “I’m an investor. You’re an investor. The folks watching are investors, and there’s an incredible amount…
Intel appoints Lip-Bu Tan as CEO. Courtesy: Intel New Intel CEO Lip-Bu Tan will receive total compensation of $1 million in salary and about $66 million in stock options and grants vesting over the coming years, according to filing on Friday with the SEC. Tan was named as the chief of Intel this week, spurring…
Docusign rose more than 14% after reporting stronger-than-expected earnings after the bell Thursday. “We’ve really stabilized and I think started to turn the corner on the core business,” CEO Allan Thygesen said Friday on CNBC’s “Squawk Box.” “We’ve become much more efficient.” Here’s how the company performed in the fourth quarter FY2025 compared to LSEG…
Consumer sentiment took another hit in March as worries intensified over inflation and a slumping stock market, according to the University of Michigan’s latest sentiment survey released Friday. The survey posted a mid-month reading of 57.9, which represents a 10.5% decline from February and was below the Dow Jones consensus estimate for 63.2. The reading…
Major U.S. indexes and DJT stock performance since election day.
JPMorgan touts Bristol Myers Squibb as a top biopharma pick. Jim Cramer is also quite fond of it. The news In a Friday note, JPMorgan analysts said Bristol Myers is well positioned to “further re-rate” as Cobenfy goes wider. The oral drug designed to help treat adults with schizophrenia has the potential to reach peak…
CNBC’s Jim Cramer walked investors through next week on Wall Street, telling them to take note of the Federal Reserve’s next meeting and earnings reports from companies including FedEx, Micron and General Mills. He also warned that regardless of earnings, market action will likely be shaped by President Donald Trump and the Fed. “No matter…
In this photo illustration, the logo for the US tech firm “Block” is displayed and reflected in a number of digital screens on March 03, 2023 in London, England. Leon Neal | Getty Images With its stock down more than 30% this year and revenue growth slowing, Jack Dorsey’s Block is going bigger in lending….